Although most HIV-infected subjects have a high frequency of HIV-specific CD8 T lymphocytes, the targeted immune response fails to control HIV production. This suggests that the function of antiviral CD8 T cells, important in the control of most viral infections, is impaired in vivo in HIV-infection. Peripheral blood cells freshly isolated from HIV-infected donors frequently lack detectable HIV-specific cytotoxicity. Preliminary studies suggest that lack of protective CD8 T cell-mediated immunosurveillance could be due to defects in T cell signaling, lack of expression of the key cytolytic effector molecule perforin, or to inefficient trafficking to lymphoid sites of HIV infection. HIV-specific CD8 T cells stained with MHC-peptide tetramers have down-modulated the key T cell signaling molecules CD3C; and CD28, frequently do not express perforin, and do not express the molecules required for efficient trafficking to lymphoid tissue. Moreover, cells with down-modulated CD3< do not express the high affinity IL-2 receptor or produce IL-2 after activation. In more advanced patients, the level of CD8 T cell dysfunction may be more severe. The proportion of CD8 T cells with down-modulated CD34 is greater and does not reverse with IL-2, as it does in less advanced donor samples. Moreover, CD8 T cell activation and IFNy production in response to HIV-infected CD4 T cells in advanced patients does not occur unless exogenous IL-2 is provided. The goal of this proposal is to sort out the relative importance of each of these possible impediments to CD8 T cell control of HIV infection and determine whether they are part of normal immune regulation, secondary to chronic antigenic stimulation or inflammation, or specific to HIV infection. In particular, CD8 T cells specific for HIV will be compared to those specific for a self-limited infection and other chronic infections in normal and HIV-infected donors. The properties of HIV-specific CD8 T cells in the blood and in the lymphoid tissues will also be compared. CD8 T cell function and characteristics will be analyzed at different stages of disease, with special emphasis on a comparison between early stage donors with and without intact proliferative responses to HIV gag to test the hypothesis that deficiencies in CD4 helper cell function are responsible for the lack of protective CD8 T cell function. In vitro experiments will be performed to dissect the relative importance of signaling and perforin defects in impaired HIV-specific cytotoxicity and to explore what factors regulate and can reverse impaired CD8 T cell function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042519-07
Application #
6871954
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Plaeger, Susan F
Project Start
1998-04-01
Project End
2006-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
7
Fiscal Year
2005
Total Cost
$473,000
Indirect Cost
Name
Immune Disease Institute, Inc.
Department
Type
DUNS #
059709394
City
Boston
State
MA
Country
United States
Zip Code
02115
Lieberman, Judy (2004) Tracking the killers: how should we measure CD8 T cells in HIV infection? AIDS 18:1489-93
Ince, M Nedim; Harnisch, Brooke; Xu, Zhan et al. (2004) Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 112:531-42
Lange, Christoph G; Xu, Zhan; Patterson, Bruce K et al. (2004) Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS 18:605-13
Mackewicz, Carl E; Wang, Baikun; Metkar, Sunil et al. (2003) Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules. Blood 102:180-3
Song, Erwei; Lee, Sang-Kyung; Dykxhoorn, Derek M et al. (2003) Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J Virol 77:7174-81
Zhang, Dong; Shankar, Premlata; Xu, Zhan et al. (2003) Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 101:226-35
Lieberman, Judy; Manjunath, N; Shankar, Premlata (2002) Avoiding the kiss of death: how HIV and other chronic viruses survive. Curr Opin Immunol 14:478-86
Lieberman, J; Shankar, P; Manjunath, N et al. (2001) Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98:1667-77
Chen, G; Shankar, P; Lange, C et al. (2001) CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98:156-64
Trimble, L A; Kam, L W; Friedman, R S et al. (2000) CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood 96:1021-9

Showing the most recent 10 out of 13 publications